©2022 Stanford Medicine
Cool Prime Comparative Effectiveness Study for Mild HIE
Not Recruiting
Trial ID: NCT04621279
Purpose
To determine effectiveness of therapy to improve neurodevelopmental outcomes in infants with
mild HIE. To determine the adverse effects of Therapeutic Hypothermia (TH) in mild HIE on the
neonate and his/her family. Determine heterogeneity of the treatment effect across key
subgroups obtained in the first 6 hours after birth prior to the decision to initiate
therapy.
Official Title
COOLPRIME: Comparative Effectiveness for Cooling Prospectively Infants With Mild Encephalopathy
Stanford Investigator(s)
Eligibility
Inclusion Criteria:
Infants must meet all 3 inclusion criteria
1. Neonates born at ≥ 35 0/7 weeks
2. Mild Encephalopathy on neonatal neurologic exam within 6 hours after birth: defined as
presence of at least 2 signs of mild, moderate, or severe encephalopathy with no more
than 2 signs in the moderate or severe category.
3. Perinatal Acidosis based on at least one of the following (A or B):
1. pH ≤ 7.00 in any cord or first infant gas (arterial, venous, or capillary) within
≤ 60 min OR base deficit ≥ 16 in any cord or first infant gas (arterial, venous
or capillary) within ≤ 60 min
2. If pH is between 7.01 and 7.15, OR base deficit is between 10 and 15.9
mmol/liter, OR blood gas is not available, an acute perinatal event is an
additional criteria required (see below definition)
An acute perinatal event is defined by at least one of the following:
1. Apgar score at 10 min ≤ 5
2. Continued need for resuscitation at 10 min (chest compressions, bag mask ventilation,
or positive pressure ventilation)
3. Uterine rupture, placental abruption, cord accident (prolapse, rupture, knot or tight
nuchal cord)
4. maternal trauma, maternal hemorrhage, or cardiorespiratory arrest
5. fetal exsanguination from either vasa previa or feto-maternal hemorrhage, shoulder
dystocia
Exclusion Criteria:
1. Gestational age at birth < 35 0/7 weeks
2. Birth weight < 1800gm
3. Head circumference <30cm
4. Congenital or chromosomal anomaly associated with abnormal neurodevelopment or death
5. Moderate or Severe HIE of 3 or more moderate or severe abnormalities on COOLPRIME
Sarnat exam within 6 hours of life
6. Any seizures within first six hours of life
7. Redirection of care is being considered
Intervention(s):
procedure: Normothermia
procedure: Whole body therapeutic hypothermia
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305